2025 Annual Report of Independent Director
Dear shareholders and representatives:
Hello! As the independent director of Jiangsu Baoxin Technology Co., Ltd. (hereinafter referred to as "the Company"), I have strictly adhered to the provisions and requirements of the Company Law, the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 - Standard Operation of Main Board Listed Companies, and the Articles of Association during 2025. I have diligently and independently fulfilled my duties, actively attended relevant meetings, carefully reviewed various proposals from the board of directors, and fully exercised the role of independent director to protect the rights and interests of the Company and all shareholders. Below is my performance report during my term:
I. Basic Information of the Independent Director
Mr. Gao Pengcheng: Born in 1988, Chinese nationality, no permanent residency abroad, Master of Laws. Previously served as an independent director of Xuancheng Hualing Precision Technology Co., Ltd., currently a partner at Beijing Dacheng (Nanjing) Law Firm and an independent director of the Company. During the reporting period, my position met the independence requirements stipulated in Article 6 of the Management Measures for Independent Directors of Listed Companies, and there were no circumstances affecting my independence.
II. Annual Performance Overview of the Independent Director
(A) Attendance at Board and Shareholder Meetings
During the reporting period, the Company held 18 board meetings and 3 shareholder meetings. I personally attended all 18 board meetings and all 3 shareholder meetings, and after careful review of the board's proposals and other matters, I voted in favor (except in cases of abstention), with no objections.
(B) Participation in Board Committees
During the reporting period, I served as the chairman of the Nomination Committee, chairman of the Remuneration and Assessment Committee, and a member of the Audit Committee of the sixth board of directors. I strictly adhered to the relevant regulations of the Company Law, the Corporate Governance Code for Listed Companies, and the Management Measures for Independent Directors of Listed Companies, as well as the rules of procedure for the meetings of each specialized committee. My main work is reported as follows:
- As the chairman of the Nomination Committee, I presided over 4 meetings, reviewing matters related to the re-election of the board of directors, the appointment of senior management, and the supplementary election of directors, and provided opinions.
- As the chairman of the Remuneration and Assessment Committee, I presided over 2 meetings and participated in 2 meetings, reviewing matters related to director allowances and the cancellation of certain stock options from the 2022 stock option incentive plan, and provided opinions.
- As a member of the Audit Committee, I participated in 8 meetings, reviewing the Company's 2025 semi-annual report, 2025 third-quarter report, and other related matters, and provided opinions.